Information  X 
Enter a valid email address

Bakkavor Group PLC (BAKK)

  Print      Mail a friend

Thursday 13 June, 2019

Bakkavor Group PLC

Acquisition

RNS Number : 0191C
Bakkavor Group PLC
13 June 2019
 

 

 

13 June 2019

 

Bakkavor Group plc

 

Completion of Acquisition of Blueberry Foods

 

Bakkavor Group plc is pleased to confirm the completion of the acquisition of Blueberry Foods, previously announced on 16 May 2019.

 

 

ENQUIRIES

Institutional investors and analysts:

Peter Gates, Chief Financial Officer                                                                                       

Sally Barrett-Jolley, Head of Corporate Affairs                                                  +44 (0) 20 7908 6143                                                                                                                            

 

Media enquiries:

Tulchan Communications                                                                                  +44 (0) 20 7353 4200

Catherine James, Will Smith, Will Palfreyman

 

DISCLAIMER - FORWARD-LOOKING STATEMENTS

This statement may contain forward-looking statements about the Group. Forward-looking statements involve uncertainties because they relate to events, and depend on circumstances, that will, or may, occur in the future. If the assumptions on which the Group bases its forward-looking statements change, actual results may differ from those expressed in such statements. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update these forward-looking statements. Nothing in this statement should be construed as a profit forecast. Some numbers and period on period percentages in this statement have been rounded or adjusted in order to ensure consistency with the financial information.

 

LEI number: 213800COL7AD54YU9949

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACQEASKAFDKNEFF

a d v e r t i s e m e n t